[sheet: Cover]
Field | Detail
Document Title | LPA and Side Letter Negotiation Tracker — Issues and Resolutions
Matter | Pellegrino Capital Group LLC Co-Investment alongside Ridgeline Equity Partners Fund IV, L.P.
Matter No. | 1027-00002
Client | Pellegrino Capital Group LLC
Client Contact | Adriana Voss, VP & General Counsel; Marco A. Pellegrino, Founder & Managing Member
Counterparty Counsel | Hartwell Velmoran & Pratt LLP (Douglas W. Cheng, Partner; Meredith L. Tanaka, Associate)
Co-Invest Vehicle | Ridgeline-Clarion Co-Invest, L.P.
Co-Invest GP | Ridgeline-Clarion Co-Invest GP LLC
PCG Commitment | $25,000,000 (33.33% of $75,000,000 co-invest vehicle)
Negotiation Period | November 25, 2025 – January 24, 2026
First Draft LPA Received | November 25, 2025 (from Hartwell Velmoran & Pratt LLP)
C&H Initial Markup Delivered | December 6, 2025
Side Letter First Draft | December 10, 2025 (drafted by Calderwood & Harkness)
Negotiation Calls | January 6–17, 2026
Final Forms Agreed | January 24, 2026
Target Closing Date | January 30, 2026
Prepared By | Owen Fischer (Lead Associate) and Stephen Adler (Working Associate)
Supervised By | Nicholas Stern (Responsible Partner)
Firm | Calderwood & Harkness LLP, 200 South Biscayne Boulevard, Suite 4100, Miami, FL 33131
Classification | PRIVILEGED & CONFIDENTIAL — Attorney Work Product
Governing Law (LPA / Side Letter) | State of Delaware
[sheet: LPA Negotiation Tracker]
Item # | Category | LPA Section | Issue / Provision | Hartwell Velmoran Initial Draft Position (Nov 25, 2025) | Pellegrino / C&H Ask (Dec 6, 2025 Markup) | Negotiation Notes / Call Discussion | Resolution / Agreed Language | Status | Date Resolved | C&H Attorney
1 | Economics — Carried Interest | Section 5.1(a) | Carried interest rate and calculation methodology | 15% carried interest on net profits above a 7% preferred return; carry calculated on aggregate vehicle basis | Reduce carry to 10% (market for co-invest); increase preferred return to 8% compounded quarterly; carry calculated on deal-by-deal basis | Discussed on Jan 7 call. Sponsor pushed back on deal-by-deal carry calc. Agreed to whole-fund carry but with reduced rate. Confirmed 8% pref compounded quarterly acceptable to sponsor. | 10% carried interest on net profits above 8% preferred return compounded quarterly; whole-fund (aggregate) carry calculation | Agreed | January 10, 2026 | O. Fischer
2 | Economics — Preferred Return | Section 5.1(b) | Preferred return rate and compounding | 7% per annum preferred return, compounded annually | 8% per annum, compounded quarterly | Discussed on Jan 7 call. Sponsor agreed to 8% rate. Compounding quarterly accepted after C&H noted market standard for co-invest vehicles. | 8% per annum preferred return, compounded quarterly | Agreed | January 10, 2026 | O. Fischer
3 | Economics — Management Fee | Section 5.2 | Management fee on co-invest vehicle | 0.50% per annum on committed capital during investment period; 0.50% on invested capital thereafter | 0% management fee (standard for co-invest vehicles alongside Fund IV) | Jan 7 call — sponsor initially resisted full waiver; C&H cited market practice. Sponsor conceded on Jan 9 follow-up. | 0% management fee for the life of the co-invest vehicle | Agreed | January 9, 2026 | O. Fischer
4 | Economics — Organizational Expenses | Section 5.3 | Cap on organizational expenses borne by co-investors | $250,000 cap, allocated pro rata among LPs | Reduce to $150,000 cap, allocated pro rata based on capital commitments | Discussed Jan 8. Sponsor agreed to $150,000 cap. | $150,000 organizational expenses cap, borne pro rata by co-investors based on capital commitments | Agreed | January 8, 2026 | S. Adler
5 | Economics — GP Clawback | Section 5.4 | GP obligation to return excess carried interest at liquidation | No GP clawback provision included in initial draft | Insert 100% GP clawback of excess carried interest at liquidation, with interim true-up annually | Strong push from C&H on Jan 7 and Jan 10 calls. Sponsor agreed to clawback at liquidation but resisted interim annual true-up. Compromise: clawback at liquidation only. | 100% GP clawback of excess carried interest, tested and payable at liquidation of the vehicle | Agreed | January 13, 2026 | O. Fischer
6 | Economics — Distribution Waterfall | Section 5.5 | Order of distributions | Standard four-tier waterfall: (i) return of capital, (ii) preferred return, (iii) GP catch-up, (iv) 85/15 split | Modify to: (i) return of capital, (ii) 8% preferred return (compounded quarterly), (iii) GP catch-up to 10% carry, (iv) 90/10 split consistent with 10% carry | Agreed consistent with carry reduction to 10%. | Four-tier waterfall: (i) return of capital, (ii) 8% preferred return, (iii) GP catch-up to 10%, (iv) 90/10 split (LPs/GP) | Agreed | January 10, 2026 | O. Fischer
7 | Governance — LPAC | Section 7.1 | Limited Partner Advisory Committee composition and rights | 3-member LPAC; GP to appoint all members at its discretion | Pellegrino entitled to one designated seat on the 3-member LPAC as of right; LPAC to have consent rights on conflicts of interest and related-party transactions | Discussed Jan 8. Sponsor agreed to Pellegrino's designated seat (to be documented in side letter). LPAC consent rights on conflicts accepted. | 3-member LPAC; Pellegrino entitled to one seat (per side letter); LPAC consent rights on GP conflicts and related-party transactions | Agreed (LPA + Side Letter) | January 13, 2026 | O. Fischer
8 | Governance — Key Person | Section 7.3 | Key person provisions and trigger events | No key person provision in initial draft | Insert key person clause: Julian T. Whitmore and Connor M. Rafferty as key persons; trigger if both cease active involvement; upon trigger, investment period suspended and LP vote required to continue or wind down | Sponsor pushed back on naming Whitmore (firm-wide leader); C&H insisted both must be named given hospitality sector expertise. Agreed on Jan 14 call after Rafferty's centrality to deal acknowledged. | Key person trigger if both Julian T. Whitmore and Connor M. Rafferty cease active involvement in management of the investment; upon trigger, investment period suspended pending majority LP vote | Agreed | January 14, 2026 | O. Fischer
9 | Governance — Removal of GP | Section 7.4 | Ability of LPs to remove GP for cause | GP removal only upon fraud, gross negligence, or willful misconduct, requiring 75% LP vote | Reduce threshold to 66.67% LP vote; expand 'cause' definition to include material breach of LPA uncured for 30 days | Sponsor resisted expanding cause definition. Compromise reached on Jan 15: cause expanded to include material breach with 60-day cure period; vote threshold remains at 75%. | GP removal for cause (fraud, gross negligence, willful misconduct, or material uncured breach after 60-day cure period); requires 75% LP vote by commitment | Agreed | January 15, 2026 | O. Fischer
10 | Capital Calls — Mechanics | Section 3.1 | Capital call notice period and funding mechanics | 5 business days' prior written notice for capital calls | Extend to 10 business days' prior written notice; initial capital call of 100% of committed capital ($25,000,000) due at closing | Agreed on Jan 8 call. Sponsor accepted 10 business days as reasonable. | 10 business days' prior written notice for capital calls; 100% of committed capital called at closing (January 30, 2026 funding deadline) | Agreed | January 8, 2026 | S. Adler
11 | Capital Calls — Defaults | Section 3.3 | Default remedies for failure to fund capital call | 100% forfeiture of defaulting LP's interest; non-defaulting LPs may elect to fund the shortfall | Reduce forfeiture to 50% of defaulting LP's interest; remaining 50% subordinated to non-defaulting LPs; 5 business day cure period before default declared | Discussed Jan 9. Sponsor conceded on 50% forfeiture with subordination. Cure period negotiated to 3 business days (compromise from 5). | Forfeiture of 50% of defaulting LP's interest; remaining 50% subordinated to distributions to non-defaulting LPs; 3 business day cure period | Agreed | January 13, 2026 | S. Adler
12 | Transfers — Restrictions | Section 8.1 | Transfer restrictions on LP interests | No transfers without prior written GP consent (sole discretion); no ROFR | GP consent required (not to be unreasonably withheld); insert ROFR in favor of GP and other co-investors; transfers to affiliates and family members permitted without consent | Sponsor agreed to ROFR. GP consent standard remained at sole discretion but with carve-out for permitted transfers (affiliates and estate planning vehicles). No family member carve-out. | No transfers without GP consent (sole discretion); ROFR in favor of GP and other co-investors on any proposed transfer; permitted transfers to affiliates and estate planning vehicles without GP consent (subject to notice) | Agreed | January 14, 2026 | S. Adler
13 | Transfers — Tag-Along Rights | Section 8.2 | Tag-along rights on sale by Ridgeline Fund IV | No tag-along provision in initial draft | Full tag-along right on any sale by Ridgeline Fund IV of its interest in AcquisitionCo; co-investors to participate pro rata on same terms and conditions | Discussed Jan 10 and Jan 14. Sponsor initially offered tag only on 100% sale. C&H pushed for full tag on any partial or total disposition. Agreed to full tag on Jan 16 call. | Full tag-along right for co-investors on any sale (partial or total) by Ridgeline Fund IV of its interest in Clarion Holdings Acquisition Corp., on same price, terms, and conditions, pro rata | Agreed | January 16, 2026 | O. Fischer
14 | Transfers — Drag-Along Rights | Section 8.3 | Drag-along rights of GP / sponsor | GP may drag all co-investors on a sale of 50% or more of AcquisitionCo at any time | Limit drag to sale of 100% of AcquisitionCo only; drag must be at fair market value; co-investors receive same per-unit consideration as Fund IV | Sponsor agreed to limit drag to 100% sales. Fair market value standard and same per-unit price accepted. | GP may drag co-investors only on a sale of 100% of AcquisitionCo; sale must be at fair market value; co-investors receive same per-unit consideration as Ridgeline Fund IV | Agreed | January 16, 2026 | O. Fischer
15 | Reporting — Information Rights | Section 9.1 | Scope and timing of financial reporting to LPs | Annual audited financials within 180 days of fiscal year-end; quarterly unaudited financials within 90 days of quarter-end; K-1s by April 15 | Annual audited financials within 120 days; quarterly unaudited within 60 days; K-1s by March 15; add annual investor meeting | Discussed Jan 8. Sponsor agreed to tighten deadlines to 120 days / 60 days / March 15. Annual investor meeting rejected but annual written update letter agreed. | Annual audited financials within 120 days of fiscal year-end; quarterly unaudited financials within 60 days of quarter-end; Schedule K-1s by March 15 of each year; annual written portfolio update | Agreed | January 13, 2026 | S. Adler
16 | Reporting — Enhanced Reporting (Side Letter) | Section 9.2 / Side Letter | Monthly operating dashboards for Clarion — Pellegrino-specific | Not addressed in initial LPA draft | Monthly operating dashboards for Clarion Hospitality Holdings, Inc. within 30 days of month-end (to be documented in side letter) | Sponsor agreed to provide as side letter accommodation given Pellegrino's hospitality expertise and commitment size. | Monthly operating dashboards within 30 days of month-end; documented in Pellegrino side letter | Agreed (Side Letter) | January 14, 2026 | O. Fischer
17 | Tax — Allocation Methodology | Section 6.1 | Tax allocation provisions under IRC Sections 704(b) and 704(c) | Standard 704(b) allocations; 704(c) remedial method; no specific co-investor protections | Confirm 704(b) economic effect equivalence; traditional method with curative allocations under 704(c); add tax distribution provisions (minimum distributions to cover LP tax liabilities) | Discussed Jan 10. Sponsor agreed to add tax distribution provision. 704(c) method remains remedial (sponsor preference); C&H conceded after coordinating with Whitfield Greer & Associates LLP (Robert K. Anand). | 704(b) allocations with economic effect equivalence; 704(c) remedial method; tax distribution provision requiring minimum distributions to cover estimated LP tax liabilities on allocated income | Agreed | January 15, 2026 | O. Fischer / S. Adler
18 | Tax — Withholding | Section 6.3 | Tax withholding obligations and indemnification | GP authorized to withhold taxes as required; amounts treated as distributions to affected LP | Acceptable as drafted; add requirement that GP provide 10 business days' advance notice of any withholding | Agreed on Jan 9. Minor point. | GP authorized to withhold; amounts treated as distributions; GP to provide 10 business days' advance notice of any withholding | Agreed | January 9, 2026 | S. Adler
19 | Defaults — Cure Period | Section 10.1 | Notice and cure periods for LP defaults (non-funding) | Immediate default upon failure to fund; no cure period | Insert 5 business day cure period after written notice of default before forfeiture remedies apply | Compromise reached at 3 business days (see Item 11 above). Consistent treatment across all default provisions. | 3 business day cure period after written notice before default remedies (forfeiture/subordination) take effect | Agreed | January 13, 2026 | S. Adler
20 | Excuse / Exclusion | Section 4.2 | Right of LPs to be excused from investment; GP right to exclude LPs | GP has sole discretion to excuse or exclude any LP from the investment for any reason | Narrow excuse rights: LP may be excused only for bona fide legal or regulatory conflict (subject to GP approval, not to be unreasonably withheld); GP may not exclude any LP without LP's prior written consent | Discussed Jan 14. Sponsor agreed to narrow excuse/exclusion. Consent-based exclusion accepted. Additional protection for Pellegrino specifically documented in side letter. | LP excuse only for legal/regulatory conflict, subject to GP approval (not to be unreasonably withheld); GP may not exclude any LP without such LP's prior written consent | Agreed (LPA + Side Letter) | January 16, 2026 | O. Fischer
21 | Term & Extensions | Section 11.1 | Term of the co-invest vehicle and GP extension rights | 10-year term from initial closing; three 1-year GP extensions at sole discretion | 10-year term; limit to two 1-year GP extensions; extensions require LP advisory committee consent | Sponsor agreed to two extensions. LPAC consent on extensions rejected; GP retains sole discretion on extensions. | 10-year term from initial closing with two 1-year GP extensions at GP's sole discretion | Agreed | January 10, 2026 | O. Fischer
22 | Investment Period | Section 2.3 | Investment period and follow-on commitment obligations | Investment period co-terminous with Ridgeline Fund IV; LPs may be required to fund follow-on investments up to 15% of original commitment | No follow-on commitment; co-invest vehicle limited to initial investment only | Discussed Jan 7. Sponsor agreed — co-invest vehicle is single-investment, no follow-on obligation. | Investment period co-terminous with Ridgeline Equity Partners Fund IV, L.P.; initial investment only, no follow-on commitment obligation | Agreed | January 7, 2026 | O. Fischer
23 | Indemnification | Section 12.1 | Indemnification of GP and its affiliates | Broad indemnification of GP, its affiliates, officers, directors, employees; carve-out only for fraud | Narrow carve-out to exclude gross negligence, willful misconduct, and material breach of LPA in addition to fraud; cap LP indemnification obligation at LP's unfunded commitment | Sponsor agreed to expand carve-outs to include gross negligence and willful misconduct. Cap on LP indemnification at total capital commitment (not unfunded only) — compromise from C&H's position. | Indemnification of GP-related persons except for fraud, gross negligence, or willful misconduct; LP indemnification obligation capped at such LP's total capital commitment | Agreed | January 15, 2026 | O. Fischer
24 | Confidentiality | Section 13.1 | Confidentiality obligations of LPs | Broad confidentiality covering all information; no carve-outs; 3-year survival post-termination | Add customary carve-outs for disclosures required by law, regulation, court order, or to LP's own advisors and affiliates under NDA; reduce survival to 2 years | Agreed on Jan 9. Standard carve-outs accepted. Survival period at 2 years. | Confidentiality obligations with carve-outs for legally required disclosures, disclosures to LP advisors/affiliates under NDA; 2-year survival post-termination | Agreed | January 9, 2026 | S. Adler
25 | Co-Investment with Fund IV — Parallel Terms | Section 2.1 | Co-invest vehicle's relationship to Ridgeline Fund IV | Co-invest vehicle invests alongside Fund IV in Clarion Holdings Acquisition Corp.; no specific requirement for pari passu treatment | Add covenant that co-invest vehicle shall be treated pari passu with Fund IV on all economic terms (price per unit, distribution priority, exit timing) | Discussed Jan 10. Sponsor agreed to pari passu pricing and exit timing. Distribution priority follows co-invest waterfall (separate from Fund IV's 20% carry structure). | Co-invest vehicle invests on pari passu basis with Ridgeline Fund IV as to price per unit and exit timing; distribution waterfall per co-invest LPA terms (10% carry vs. Fund IV's 20%) | Agreed | January 13, 2026 | O. Fischer
26 | Amendments | Section 14.1 | Amendment process for the LPA | GP may amend LPA with consent of majority in interest of LPs; GP may make non-material amendments without LP consent | Material amendments require 66.67% LP consent; any amendment adversely affecting a specific LP's economics requires that LP's consent; define 'material amendment' | Sponsor agreed to specific-LP consent for adverse economic changes. Material amendment definition added. Threshold remains majority in interest for general amendments. | Amendments require majority in interest LP consent; amendments adversely affecting a specific LP's economic rights require that LP's consent; GP may make non-material technical/administrative amendments without LP consent | Agreed | January 16, 2026 | O. Fischer
27 | Valuation | Section 6.5 | Valuation methodology for portfolio company | GP determines fair market value in its sole discretion annually | Require annual independent third-party valuation; if disputed, LP may request second opinion at LP's expense | Sponsor rejected mandatory independent valuation. Compromise: GP determines FMV in good faith consistent with GAAP/ASC 820; independent valuation available upon request of LPAC at vehicle expense. | GP determines FMV in good faith consistent with ASC 820; independent valuation upon LPAC request at vehicle expense | Agreed | January 17, 2026 | O. Fischer
[sheet: Side Letter Tracker]
Item # | Side Letter Provision | Initial C&H Draft Position (Dec 10, 2025) | Hartwell Velmoran Response | Negotiation Notes | Resolution / Agreed Language | Status | Date Resolved | C&H Attorney
1 | Most-Favored-Nation (MFN) Protection | Full MFN: Pellegrino entitled to elect any more favorable term granted to any other co-investor in the vehicle, whether in the LPA, a side letter, or otherwise | Sponsor proposed limited MFN — excludes fee and carry concessions to anchor LPs committing >$30M | Jan 13 call: C&H insisted on full MFN with no exclusions given PCG's $25M commitment (33.33% of vehicle). Sponsor conceded. | Full most-favored-nation protection; Pellegrino entitled to elect any more favorable term granted to any other co-investor, without exclusion | Agreed | January 14, 2026 | O. Fischer
2 | LPAC Seat | Pellegrino designated to one seat on the 3-member LPAC of the Co-Invest Vehicle as of right for so long as it holds at least 75% of its original commitment | Sponsor accepted but proposed threshold of 100% of original commitment maintained | Compromise at 75% threshold on Jan 14. | Pellegrino entitled to one seat on the 3-member Co-Invest Vehicle LPAC, for so long as it maintains at least 75% of its original $25,000,000 commitment | Agreed | January 14, 2026 | O. Fischer
3 | Future Co-Investment Allocation | Pellegrino to receive pro rata allocation in any future Ridgeline-sponsored co-investments in the hospitality sector, subject to availability and applicable legal restrictions | Sponsor proposed best-efforts commitment only; no binding allocation right | Jan 15 call: C&H pushed for binding right subject to availability. Agreed to binding pro rata allocation right, subject to availability and legal/regulatory restrictions. | Pro rata allocation right in future Ridgeline-sponsored hospitality co-investments, subject to availability and applicable legal restrictions; binding obligation of sponsor (not merely best efforts) | Agreed | January 16, 2026 | O. Fischer
4 | Monthly Operating Dashboard Reporting | Monthly operating dashboards for Clarion Hospitality Holdings, Inc. to be delivered within 30 days of each month-end, including revenue, occupancy, ADR, RevPAR, and EBITDA metrics | Sponsor agreed in principle; requested 45-day delivery window | C&H held firm on 30 days given Pellegrino's hospitality expertise and need for timely data. Agreed at 30 days on Jan 14. | Monthly operating dashboards for Clarion within 30 days of month-end, covering revenue, occupancy, ADR, RevPAR, and EBITDA | Agreed | January 14, 2026 | S. Adler
5 | Annual ESG Reporting | Annual ESG summary consistent with Pellegrino's internal ESG policy framework, covering environmental sustainability, labor practices, and governance metrics for Clarion's managed properties | Sponsor agreed to provide annual ESG summary; requested flexibility on format and scope | Agreed on Jan 15 that format will be reasonably consistent with Pellegrino's ESG policy but not rigidly prescribed. | Annual ESG summary report consistent with Pellegrino's internal ESG policy, delivered concurrently with annual audited financials | Agreed | January 15, 2026 | S. Adler
6 | No Excuse/Exclusion without Pellegrino Consent | GP may not excuse or exclude Pellegrino from this investment without Pellegrino's prior written consent, notwithstanding any contrary provision in the LPA | Sponsor accepted without objection given LPA revisions to excuse/exclusion provisions | Confirmed on Jan 16. | GP may not excuse or exclude Pellegrino from the co-investment without Pellegrino's prior written consent | Agreed | January 16, 2026 | O. Fischer
7 | Confidentiality of Side Letter | Side letter terms confidential; GP may disclose existence and material terms to other co-investors only as required to administer MFN obligations | Sponsor requested ability to disclose to prospective co-investors during fundraising | Agreed to limited disclosure to prospective co-investors on a redacted/anonymized basis during capital raising. | Side letter confidential; GP may disclose on anonymized/redacted basis to prospective co-investors and as required to administer MFN provisions | Agreed | January 17, 2026 | S. Adler
8 | Governing Law and Dispute Resolution | Governed by the laws of the State of Delaware; disputes subject to arbitration in Wilmington, DE | Sponsor proposed New York law and arbitration in New York | C&H insisted on Delaware law for consistency with LPA. Arbitration venue negotiated to Delaware. | Governed by the laws of the State of Delaware; disputes resolved by binding arbitration in Wilmington, Delaware | Agreed | January 17, 2026 | O. Fischer
[sheet: Summary Dashboard]
Category | Total Issues | Agreed | Open | Key Wins for Pellegrino
Economics | 6 | 6 | 0 | Carry reduced from 15% to 10%; pref increased to 8% compounded quarterly; 0% mgmt fee; $150K org expense cap; 100% GP clawback at liquidation; 90/10 waterfall
Governance | 3 | 3 | 0 | LPAC seat secured; key person trigger for Whitmore & Rafferty; GP removal for expanded cause definition
Capital Calls & Defaults | 3 | 3 | 0 | 10 business day notice period; 50% forfeiture (down from 100%); 3 business day cure period added
Transfers | 3 | 3 | 0 | Full tag-along on any Fund IV disposition; drag limited to 100% sales at FMV; ROFR added
Reporting & Information | 2 | 2 | 0 | Tightened delivery deadlines (120/60 days, K-1 by March 15); monthly dashboards via side letter
Tax | 2 | 2 | 0 | Tax distribution provision added; 10 business day withholding notice
Excuse / Exclusion | 1 | 1 | 0 | Narrowed to legal/regulatory conflicts only; GP cannot exclude without LP consent
Term & Investment Period | 2 | 2 | 0 | Two 1-year extensions (reduced from three); no follow-on commitment
Indemnification | 1 | 1 | 0 | Expanded carve-outs (fraud, gross negligence, willful misconduct); LP cap at total commitment
Confidentiality | 1 | 1 | 0 | Standard carve-outs; 2-year survival
Co-Invest / Fund IV Parity | 1 | 1 | 0 | Pari passu pricing and exit timing with Fund IV
Valuation | 1 | 1 | 0 | ASC 820 good faith standard; independent valuation on LPAC request
Amendments | 1 | 1 | 0 | Adverse economic amendment requires affected LP consent
Side Letter — MFN | 1 | 1 | 0 | Full MFN with no exclusions
Side Letter — Future Co-Invest | 1 | 1 | 0 | Binding pro rata hospitality co-invest allocation right
Side Letter — Monthly Dashboard | 1 | 1 | 0 | 30-day monthly dashboards for Clarion
Side Letter — ESG | 1 | 1 | 0 | Annual ESG report per Pellegrino's internal policy
Side Letter — No Excuse/Exclusion | 1 | 1 | 0 | Prior written consent required
Side Letter — Confidentiality | 1 | 1 | 0 | Anonymized disclosure permitted for MFN administration
Side Letter — Governing Law | 1 | 1 | 0 | Delaware law; Wilmington arbitration
TOTAL | 35 | 35 | 0 | All issues resolved as of January 24, 2026
[sheet: Timeline & Call Log]
Date | Event / Action | Participants | Key Outcomes / Notes | Documents Exchanged
November 18, 2025 | Matter opened; engagement letter executed by Calderwood & Harkness LLP and Pellegrino Capital Group LLC | Nicholas Stern, Graham Sutherland, Adriana Voss | Scope of representation defined; Matter No. 1027-00002 assigned | Engagement letter
November 25, 2025 | First draft of Co-Invest LPA received from Hartwell Velmoran & Pratt LLP | Douglas W. Cheng, Meredith L. Tanaka → Owen Fischer | LPA for Ridgeline-Clarion Co-Invest, L.P.; C&H review commenced | Co-Invest LPA — Initial Hartwell Velmoran Draft
December 6, 2025 | Calderwood & Harkness initial markup of Co-Invest LPA delivered to Hartwell Velmoran | Owen Fischer, Stephen Adler, Nicholas Stern → Douglas W. Cheng | Comprehensive markup reflecting Pellegrino's requested revisions across all categories; 27 substantive issues flagged | Co-Invest LPA — C&H Redline (Dec 6, 2025)
December 10, 2025 | Side letter first draft circulated by Calderwood & Harkness | Owen Fischer → Douglas W. Cheng, Meredith L. Tanaka | Pellegrino-specific protections: MFN, LPAC seat, future co-invest allocation, monthly dashboards, ESG reporting, excuse/exclusion consent | Side Letter — C&H First Draft
December 15, 2025 | Subscription agreement draft circulated by Hartwell Velmoran | Meredith L. Tanaka → Owen Fischer | Form subscription for $25,000,000 LP interest; C&H review commenced | Subscription Agreement — Initial Draft
December 20, 2025 | Tax structuring memo received from Whitfield Greer & Associates LLP | Robert K. Anand → Owen Fischer, Adriana Voss | Analysis of Delaware LP structure, UBTI, FIRPTA, state nexus; coordinated with C&H tax analysis | Tax Structuring Memo (Whitfield Greer)
January 3, 2026 | Calderwood & Harkness tax analysis memo finalized | Owen Fischer, Stephen Adler → Nicholas Stern, Adriana Voss | Federal income tax implications; 704(b)/704(c) allocation; Section 1061 carry treatment; state nexus (DE, FL, TN, NY) | Tax Analysis Memo (C&H)
January 6, 2026 | First negotiation call — LPA economics and capital calls | Nicholas Stern, Owen Fischer (C&H); Douglas W. Cheng, Meredith L. Tanaka (HKP); Adriana Voss (PCG) | Discussed carry, preferred return, management fee, org expense cap, capital call mechanics | None
January 7, 2026 | Negotiation call — LPA economics (continued), investment period | Owen Fischer (C&H); Meredith L. Tanaka (HKP) | Agreed on 0% mgmt fee; confirmed no follow-on commitment; carry discussion continued | None
January 8, 2026 | Negotiation call — governance, LPAC, reporting | Owen Fischer, Stephen Adler (C&H); Meredith L. Tanaka (HKP) | Agreed on $150K org expense cap, 10 business day capital call notice, tightened reporting deadlines; LPAC seat discussed | None
January 9, 2026 | Negotiation call — defaults, confidentiality, tax withholding | Owen Fischer, Stephen Adler (C&H); Meredith L. Tanaka (HKP) | Agreed on 50% forfeiture, confidentiality carve-outs, withholding notice | None
January 10, 2026 | Negotiation call — carry/waterfall, tag-along, pari passu, term | Nicholas Stern, Owen Fischer (C&H); Douglas W. Cheng (HKP); Adriana Voss (PCG) | Agreed on 10% carry, 8% pref, 90/10 split, two 1-year extensions, pari passu treatment | None
January 13, 2026 | Negotiation call — GP clawback, LPAC finalization, default cure, reporting deadlines, pari passu | Owen Fischer (C&H); Douglas W. Cheng, Meredith L. Tanaka (HKP) | Agreed on 100% GP clawback at liquidation, 3 business day cure period, LPAC seat in side letter, 120/60/March 15 reporting | None
January 14, 2026 | Negotiation call — key person, transfers, tag-along, side letter (MFN, LPAC, monthly dashboards, excuse/exclusion) | Nicholas Stern, Owen Fischer (C&H); Douglas W. Cheng (HKP); Marco A. Pellegrino, Adriana Voss (PCG) | Key person trigger for Whitmore & Rafferty agreed; full tag-along; transfer ROFR; MFN without exclusions; monthly dashboard at 30 days; LPAC seat at 75% threshold | Revised LPA and Side Letter markups exchanged
January 15, 2026 | Negotiation call — GP removal, indemnification, tax allocations, ESG, future co-invest | Owen Fischer, Stephen Adler (C&H); Meredith L. Tanaka (HKP) | GP removal cause expanded; indemnification cap at total commitment; 704(c) remedial method; ESG format flexibility; binding future co-invest allocation agreed | None
January 16, 2026 | Negotiation call — drag-along, amendments, excuse/exclusion (final), side letter finalization | Owen Fischer (C&H); Douglas W. Cheng (HKP) | Drag limited to 100% sales at FMV; adverse amendment consent; excuse/exclusion consent; side letter substantially agreed | Near-final LPA and Side Letter drafts exchanged
January 17, 2026 | Final negotiation call — valuation, side letter confidentiality, governing law | Owen Fischer (C&H); Meredith L. Tanaka (HKP) | ASC 820 valuation; side letter confidentiality (anonymized disclosure); Delaware governing law for side letter; all issues resolved | Final draft markups
January 24, 2026 | Final forms of all documents agreed | All parties confirmed via email | Co-Invest LPA, Side Letter, Subscription Agreement, Investor Questionnaire finalized for execution at closing | Execution-ready versions circulated
January 30, 2026 | Target signing/closing date | All parties | Execution of all documents; $25,000,000 capital call funded; wire to Continental Fiduciary Services, Inc. (escrow) | All closing deliverables